Last reviewed · How we verify

Xe 127 (xenon (127Xe) gas)

FDA-approved active Quality 0/100

Xe 127 (generic name: xenon (127Xe) gas) is a Inhalation Diagnostic Agent drug. It is currently FDA-approved (first approved 1982).

Xenon-127 (Xe 127) is a diagnostic gas used in inhalation imaging. It is a small molecule modality that was originally developed and is currently owned by a company, but the exact details are not specified. Xe 127 was FDA approved in 1982 for use as an inhalation diagnostic agent, but the approved indications are not provided. The commercial status of Xe 127 is not specified, and key safety considerations are not detailed. As a diagnostic agent, Xe 127 is used to visualize lung function and structure.

At a glance

Generic namexenon (127Xe) gas
Drug classInhalation Diagnostic Agent
Therapeutic areaRespiratory
PhaseFDA-approved
First approval1982

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Xe 127

What is Xe 127?

Xe 127 (xenon (127Xe) gas) is a Inhalation Diagnostic Agent drug.

What is the generic name of Xe 127?

xenon (127Xe) gas is the generic (nonproprietary) name of Xe 127.

What drug class is Xe 127 in?

Xe 127 belongs to the Inhalation Diagnostic Agent class. See all Inhalation Diagnostic Agent drugs at /class/inhalation-diagnostic-agent.

When was Xe 127 approved?

Xe 127 was first approved on 1982.

What development phase is Xe 127 in?

Xe 127 is FDA-approved (marketed).

Related